A retrospective study of the chemomobilization effect of AAE regime plus rhG-CSF in acute leukemia patients

被引：0
|
作者：
Shi, J. [1 ]
Luo, Y. [2 ]
Tan, Y. [2 ]
Huang, H. [2 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou 310003, Zhejiang, Peoples R China
来源：
BONE MARROW TRANSPLANTATION | 2015年 / 50卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
AB028
引用
收藏
页码：5565 / 5565
页数：1
相关论文
共 50 条
  • [1] The effect of gradual increment in rhG-CSF dose on stem cell yields in patients with multiple myeloma mobilized with intermediate dose cyclophosphamide plus rhG-CSF
    Hacioglu, Sibel
    Sari, Ismail
    Dogu, Mehmet Hilmi
    Keskin, Ali
    TRANSFUSION AND APHERESIS SCIENCE, 2014, 50 (01) : 71 - 74
  • [2] Comparison of PEG-rhG-CSF and common rhG-CSF after induction chemotherapy in patients with newly diagnosed acute myeloid leukemia
    Liu, Kaiqi
    Wei, Hui
    Wang, Ying
    Mi, Yingchang
    Wang, Jianxiang
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] A comparative study of sequential priming and mobilisation of progenitor cells with rhG-CSF alone and high-dose cyclophosphamide plus rhG-CSF
    Knudsen, LM
    Jensen, L
    Gaarsdal, E
    Nikolaisen, K
    Johnsen, HE
    BONE MARROW TRANSPLANTATION, 2000, 26 (07) : 717 - 722
  • [4] A comparative study of sequential priming and mobilisation of progenitor cells with rhG-CSF alone and high-dose cyclophosphamide plus rhG-CSF
    LMeldgaard Knudsen
    L Jensen
    E Gaarsdal
    K Nikolaisen
    HE Johnsen
    Bone Marrow Transplantation, 2000, 26 : 717 - 722
  • [5] RhG-CSF after sequential intensive chemotherapy for newly diagnosed patients with acute myelogenous leukemia (AML).
    Sanchez, E
    Gomez, C
    Pizzuto, J
    Garcés, O
    Rubio, B
    Baez, E
    Rico, G
    Batista, B
    Duque, J
    Vega, P
    Castro, M
    Jimenez, R
    Sosa, J
    Silva, S
    Vela, J
    Rubio-Borja, M
    BLOOD, 2000, 96 (11) : 217B - 217B
  • [6] PEG-rhG-CSF versus rhG-CSF in supporting neutrophil recovery after induction chemotherapy for patients with newly diagnosed acute lymphoblastic leukemia
    Jin, Shumin
    Chang, Mengyuan
    Feng, Lei
    Hao, Yiping
    Li, Wei
    Zhou, Ying
    Jia, Ruinan
    Liu, Tingting
    Zhang, Di
    Jiang, Huihui
    Wang, Jingtao
    Zhao, Chuanli
    Ji, Chunyan
    Ye, Jingjing
    Ji, Min
    ANNALS OF HEMATOLOGY, 2025, : 1039 - 1046
  • [7] The impact of rhG-CSF on risk of recurrence after postoperative chemotherapy in NSCLC Patients: A retrospective cohort study
    Wang, Tong
    Hong, Weiwei
    Yao, Xinyuan
    Fang, Chen
    Qian, Xiaoying
    Yu, Biao
    Zhou, Bingbiao
    Ye, Xin
    Wang, Yong
    Li, Yong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 143
  • [8] A pilot study of using low dose cytosine and aclarabicin/homobarringtonine combined with rhG-CSF for patients with refractory and relapsed acute myeloid leukemia
    Wu, DP
    Shi, PM
    Wu, XJ
    Xia, XM
    Lin, BJ
    Ruan, CG
    BLOOD, 2002, 100 (11) : 261B - 261B
  • [9] A pilot study of using low dose cytosine and aclarabicin /homoharringtonine combined with RHG-CSF for patients with refractory and relapsed acute myeloid leukemia
    Xiao-Jin, W
    De-Pei, W
    Bao-Jue, L
    Ai-Ning, S
    EXPERIMENTAL HEMATOLOGY, 2003, 31 (07) : 147 - 147
  • [10] A pilot study of continuous infusion ara-C in combination with rhG-CSF in relapsed childhood acute myeloid leukemia
    Laver, J
    Shearer, P
    Krance, R
    Hurwitz, CA
    Srivastava, DK
    Weinstein, HJ
    Mirro, J
    LEUKEMIA & LYMPHOMA, 1997, 26 (5-6) : 589 - 593
12345